Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.69% |
| 2 | Technology | 12.68% |
| 3 | Financials | 12.18% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKS
1176
DELISTED
AK Steel Holding Corp
AKS
| $9.17M | 0.01% |
4,075,819
+2,125,128
| +109% | +$7.68M |
|
1177
Transocean
RIG
$5.52B
| $9.17M | 0.01% |
1,321,192
-787,954
| -37% | -$8.03M |
|
|
CLGX
1178
DELISTED
Corelogic, Inc.
CLGX
| $9.16M | 0.01% |
274,183
+23,889
| +10% | +$969K |
|
1179
Principal Financial Group
PFG
$24.6B
| $9.16M | 0.01% |
+207,306
| New | +$10.2M |
|
|
CBAY
1180
DELISTED
Cymabay Therapeutics
CBAY
| $9.15M | 0.01% |
1,163,152
+253,377
| +28% | +$2.41M |
|
1181
Darling Ingredients
DAR
$9.28B
| $9.14M | 0.01% |
475,220
-177,579
| -27% | -$3.6M |
|
|
ATVI
1182
DELISTED
Activision Blizzard
ATVI
| $9.14M | 0.01% |
196,242
-1,258,372
| -87% | -$75.3M |
|
1183
Federal Signal
FSS
$7.19B
| $9.13M | 0.01% |
458,558
+9,883
| +2% | +$225K |
|
1184
FS KKR Capital
FSK
$3.08B
| $9.12M | 0.01% |
440,275
+382,875
| +667% | +$9.53M |
|
1185
Children's Place
PLCE
$55.8M
| $9.12M | 0.01% |
101,239
+96,999
| +2,288% | +$12.1M |
|
1186
Vodafone
VOD
$37.7B
| $9.11M | 0.01% |
472,603
-1,112,292
| -70% | -$22.2M |
|
1187
Kilroy Realty
KRC
$4.5B
| $9.08M | 0.01% |
+144,337
| New | +$9.88M |
|
|
DPLO
1188
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $9.07M | 0.01% |
673,940
+44,896
| +7% | +$757K |
|
1189
BioMarin Pharmaceuticals
BMRN
$12B
| $9.05M | 0.01% |
106,292
-228,550
| -68% | -$21.7M |
|
1190
Shutterstock
SSTK
$220M
| $9.05M | 0.01% |
251,260
+69,840
| +38% | +$2.85M |
|
|
CCI.PRA
1191
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $9.02M | 0.01% |
+8,574
| New | +$9.03M |
|
1192
Compañía de Cervecerías Unidas
CCU
$2.2B
| $9.01M | 0.01% |
358,418
-100,012
| -22% | -$2.59M |
|
1193
H&R Block
HRB
$5.7B
| $8.98M | 0.01% |
354,169
-649,138
| -65% | -$17.3M |
|
1194
Kennametal
KMT
$2.71B
| $8.98M | 0.01% |
269,935
-194,501
| -42% | -$7.38M |
|
1195
W&T Offshore
WTI
$473M
| $8.95M | 0.01% |
2,171,207
+833,861
| +62% | +$5.33M |
|
1196
Corcept Therapeutics
CORT
$10.1B
| $8.94M | 0.01% |
668,837
+612,518
| +1,088% | +$8.1M |
|
1197
Employers Holdings
EIG
$912M
| $8.9M | 0.01% |
212,071
+59,111
| +39% | +$2.59M |
|
1198
CoStar Group
CSGP
$12.4B
| $8.9M | 0.01% |
263,820
-327,560
| -55% | -$12M |
|
1199
Franklin Resources
BEN
$17.3B
| $8.88M | 0.01% |
299,462
+275,303
| +1,140% | +$8.47M |
|
1200
Stratasys
SSYS
$690M
| $8.87M | 0.01% |
492,329
+410,983
| +505% | +$8.59M |
|
Similar funds
Millennium Management's Q4 2018 Portfolio in Review
As of Q4 2018, Millennium Management held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Millennium Management withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Athenahealth, Inc. worth $135M.
- Millennium Management's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Millennium Management added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Millennium Management's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Millennium Management fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Millennium Management's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Millennium Management opened 702 new positions and closed 844 in Q4 2018.
- Millennium Management's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.